Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Biopharma. Among the most popular portfolio startups of the fund, we may highlight Medinox, Medinox.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Prudence Venture Investment Corporation, startups are often financed by Taiwan Biotech, Industrial Bank of Taiwan, IBT Management Corporation. The meaningful sponsors for the fund in investment in the same round are Taiwan Biotech, Industrial Bank of Taiwan, IBT Management Corporation. In the next rounds fund is usually obtained by Taiwan Biotech, Industrial Bank of Taiwan, IBT Management Corporation.
The fund is generally included in less than 2 deals every year. The top activity for fund was in 2002. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| AARP | District of Columbia, United States, Washington |
| Aventrock Ventures | Alberta, Calgary, Canada |
| Beijing Wenhua Haihui | Beijing, Beijing, China |
| BOCGI Zheshang Capital | China, Hangzhou, Zhejiang |
| Central Exchange | China, Hong Kong, Hong Kong Island |
| DT&I | - |
| EuroFinLeading Private Equity | - |
| Evolution | California, Saratoga, United States |
| Impres Health | - |
| LMCG Investments | Boston, Massachusetts, United States |
| Mega International Commercial Bank | Taipei, Taiwan |
| QUBIS | Belfast, Northern Ireland, United Kingdom |
| Quintel Technology | New York, Rochester, United States |
| Standish Management | California, San Francisco, United States |
| Steelpoint Capital Partners | California, Solana Beach, United States |
| Suzhou Haihui Jijin | China, Jiangsu, Suzhou |
| Tianjin Jiying Keji Fazhan Hehuo Qiye | China, Guangdong, Tianjin |
| Treeline, Inc. | Massachusetts, United States, Wakefield |
| Tunisian American Enterprise Fund | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Helix Micro | $12M | 26 Jun 2008 | Milpitas, California, United States | ||
Bayhill Therapeutics | $35M | 04 May 2005 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Helix Micro | $12M | 26 Jun 2008 | Milpitas, California, United States | ||
Bayhill Therapeutics | $35M | 04 May 2005 | California, United States |
